Pantakan, Norsa .

HRN: 23-84-92  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2023
CEFUROXIME 1.5GM (VIAL)
10/08/2023
10/09/2023
IV
1.5g
PTOR
Pelvic Lap
Waiting Final Action 
10/08/2023
CEFUROXIME 1.5GM (VIAL)
10/08/2023
10/12/2023
IV
1.5g
Q8
Salpingectomy Left
Waiting Final Action 
10/09/2023
CEFUROXIME 500MG (TAB)
10/09/2023
10/16/2023
PO
500 Mg
BID
S/p Pelvic Laparotomy, Left Salphingooophorectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: